BSE NSE
Your Result on : Detailed News
Back
Nath Bio-Genes (India) consolidated net profit rises 11.78% in the June 2025 quarter
12-Jul-25   07:37 Hrs IST

Net profit of Nath Bio-Genes (India) rose 11.78% to Rs 37.28 crore in the quarter ended June 2025 as against Rs 33.35 crore during the previous quarter ended June 2024. Sales rose 16.33% to Rs 283.70 crore in the quarter ended June 2025 as against Rs 243.88 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales283.70243.88 16
OPM %13.4914.98 -
PBDT36.8634.43 7
PBT35.8833.60 7
NP37.2833.35 12

Powered by Capital Market - Live News

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)